DRUG Bright Minds Biosciences Inc.

OBB
$49.21

Bright Minds Biosciences Inc. (DRUG) is expected to report earnings on November 13, 2026, during market hours. The consensus earnings estimate is a loss of $1.07 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -36.1% since its last earnings release on August 14, 2026.

Bright Minds Biosciences Beat Consensus Estimates
Friday, August 14, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Sep 2026
Nov 13
Friday · Market Hours
Earnings Whisper
-
vs ($1.07)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $67.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bright Minds Biosciences Inc.

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.